Swiss National Bank’s Pliant Therapeutics PLRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-95,700
| Closed | -$129K | – | 2388 |
|
2025
Q1 | $129K | Hold |
95,700
| – | – | ﹤0.01% | 2397 |
|
2024
Q4 | $1.26M | Buy |
95,700
+1,500
| +2% | +$19.8K | ﹤0.01% | 2097 |
|
2024
Q3 | $1.06M | Buy |
94,200
+5,800
| +7% | +$65K | ﹤0.01% | 2194 |
|
2024
Q2 | $950K | Hold |
88,400
| – | – | ﹤0.01% | 2195 |
|
2024
Q1 | $1.32M | Hold |
88,400
| – | – | ﹤0.01% | 2080 |
|
2023
Q4 | $1.6M | Sell |
88,400
-2,700
| -3% | -$48.9K | ﹤0.01% | 1975 |
|
2023
Q3 | $1.58M | Sell |
91,100
-5,100
| -5% | -$88.4K | ﹤0.01% | 1982 |
|
2023
Q2 | $1.74M | Buy |
96,200
+3,700
| +4% | +$67K | ﹤0.01% | 1979 |
|
2023
Q1 | $2.46M | Buy |
92,500
+4,400
| +5% | +$117K | ﹤0.01% | 1710 |
|
2022
Q4 | $1.7M | Buy |
+88,100
| New | +$1.7M | ﹤0.01% | 1997 |
|
2022
Q2 | – | Sell |
-29,800
| Closed | -$209K | – | 2779 |
|
2022
Q1 | $209K | Buy |
29,800
+2,400
| +9% | +$16.8K | ﹤0.01% | 2675 |
|
2021
Q4 | $370K | Hold |
27,400
| – | – | ﹤0.01% | 2703 |
|
2021
Q3 | $463K | Hold |
27,400
| – | – | ﹤0.01% | 2592 |
|
2021
Q2 | $798K | Buy |
27,400
+3,400
| +14% | +$99K | ﹤0.01% | 2547 |
|
2021
Q1 | $944K | Hold |
24,000
| – | – | ﹤0.01% | 2364 |
|
2020
Q4 | $545K | Buy |
+24,000
| New | +$545K | ﹤0.01% | 2448 |
|